Centre Hospitalier Universitaire Vaudois
Lausanne, Canton of Vaud, CH-1011, Switzerland
NCT Number: NCT01866215
A high fructose diet increases fasting and post-prandial triglyceride (TG) concentrations in sedentary healthy human subjects.These effects may be secondary to fructose-induced hepatic de novo lipogenesis. Recent evidence indicate that exercise can prevent fructose induced dyslipidemia.This study will evaluate
1. how exercise effects the metabolic fate of oral fructose 1a) when exercise is performed before fructose ingestion 1b) when exercise is performed after fructose ingestion Metabolic effects of exercise will be assessed in healthy male subjects by measuring fructose oxidation (13CO2 production), fructose conversion into glucose (13C glucose concentrations in blood) and hepatic fructose conversion into lipid (13C palmitate-very low density lipoprotein (VLDL) concentrations in blood) after ingestion of 13C-labelled fructose meals 2. how fructose and protein modulate muscle glycogen and intramyocellular lipid repletion after exercise Healthy male subjects will be fed various fructose, glucose, lipid and whey protein meals after a glycogen/intramyocellular lipid depleting exercise. The effects of meals' composition will be assessed after 24 hours by measuring intramyocellular lipids and glycogen using proton-magnetic resonance spectroscopy (MRS).
Looking for future studies?
Notify Me18 year–40 year
Male
Interventional
Not applicable
Lausanne, Canton of Vaud, CH-1011, Switzerland
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
cycling at 100W during 60 min
isocaloric nutrition with fructose, cream and whey protein during the 24 hour following a glycogen/intramyocellular lipid depleting exercise
isocaloric nutrition with glucose, cream and whey protein during the 24 hour following a glycogen/intramyocellular lipid depleting exercise
Time frame: measurements in fasting conditions and every hour from 7:00 am to 4:00 pm (up to 9 hours)
measurement of total and VLDL-TG concentrations in study 1
Time frame: after glycogen/intramyocellular lipid depleting exercise and after 24 hour controlled feeding post exercise
Measurement by 1H-MRS in muscle vastus lateralis in study 2
Time frame: measured from 7:00 am to 4:00 pm in study 1 (up to 9 hours)
Estimated from 13C palmitate-VLDL concentration
Time frame: measured between 7:00 am and 4:oo pm (up to 9 hours)
measurements obtained from plasma 13C glucose concentrations and whole body glucose production measured by 6,6 d2 glucose in study 1)
Time frame: after glycogen/intramyocellular lipid depleting exercise and after 24 hour controlled feeding post exercise
Measured by 1H-MRS in muscle vastus lateralis in study 2
Time frame: measured from 7:00 am to 4:00 pm in study 1 (up to 9 hours)
Calculated from breath 13CO2 production
Time frame: measured from 7:00 am to 4:00 pm in study 2 (up to 9 hours)
Lipids ingested will be labeled with 13C-triolein, and exogenous lipid oxidation will be measured from breath 13CO2 production
University of Lausanne
Other
Acronym: FruEx2
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07470125
Healthy Subjects
Seoul, South Korea
View Trial DetailsNCT06818032
Healthy, Healthy Adult
Burlington, Vermont, United States
View Trial DetailsNCT00761631
Healthy Subjects
Benton, Arkansas, United States
View Trial DetailsNCT02610465
Cardiac-Related Conditions, Healthy Subjects
Bethesda, Maryland, United States
View Trial Details